Advertisement

Manipulation of Th Responses by Oral Tolerance

  • G. Garcia
  • H. L. Weiner
Part of the Current Topics in Microbiology and Immunology book series (CT MICROBIOLOGY, volume 238)

Abstract

The gastrointestinal tract is the major site of antigenic contact in the body. A complex and precise gastrointestinal immune system allows the accomplishment of two distinct features: absorption of nutrients avoiding hypersensitivity to food antigens and exclusion of microbiologic pathogens (Kagnoee 1996; Newby 1984; Strobel 1990).

Keywords

Experimental Autoimmune Encephalomyelitis Myelin Basic Protein Cholera Toxin Oral Tolerance Popliteal Lymph Node 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Abreu-Martin MT, Targan SR (1996) Lamina propria lymphocytes: A unique population of mucosal lymphocytes. In: Kagnoll’ M F, H Kiyono (eds) Essentials of mucosal immunology Academic, San Diego, pp 227-245Google Scholar
  2. Al-Sabbagh A, Garcia G, Slavin A, Weiner HL, Nelson P (1997) Combination therapy with oral myelin basic protein and oral methotrexate enhances suppression of experimental autoimmune encephalomyelitis. Neurology 45: A421Google Scholar
  3. Al-Sabbagh A, Miller A, Santos LMB, Weiner HL (1994) Antigen-driven tissue-specific suppression following oral tolerance: orally administered myelin basic protein suppresses proteolipid induced experimental autoimmune encephalomyelitis in the SJL mouse. Eur J Immunol 24: 2104–2109PubMedGoogle Scholar
  4. Al-Sabbagh A, Nelson P, Sobel RA, Weiner HL (1996) Antigen-driven peripheral immune tolerance: suppression of experimental autoimmune encephalomyelitis and collagen induced arthritis by aerosol administration of myelin basic protein or type II collagen. Cell Immunol 171: 111 119Google Scholar
  5. Allen JB, Wong HL, Costa GL, Bienkowski MJ, Wahl SM (1993) Suppression of monocyte function and differential regulation of IL-1 and IL-lra by IL-4 contribute to resolution of experimental arthritis. J Immunol 151: 4344–4351PubMedGoogle Scholar
  6. Andre C, Heremans JF, Vaerman JP, Cambiaso CL (1975) A mechanism for the induction of immu- nological tolerance by antigen feeding: antigen-antibody complexes. J Exp Med 142: 1509 1519Google Scholar
  7. Bagot M, Charue D, Flechet ML, Terki N, Toma A, Revuz J (1995) Oral desensitization in nickel allergy induces a decrease in nickel-specific T-cells. Eur J Dermatol 5: 614 617Google Scholar
  8. Barnett ML, Kremer JM, St. Claair EW, Clegg DO, Furst D, Weisman M, Fletcher M.IF, Lavin PT, Finger E, Morales A, Le CH, Trentham DE (1998) Treatment of rheumatoid arthritis with oral type Il collagen: results of a multicenter double-blind placebo controlled trial. Arthritis Rheum 41: 290 297sGoogle Scholar
  9. Burnett ML, Combitchi D, Trentham DE (1996) A pilot trial of oral type II collagen in the treatment of juvenile rheumatoid arthritis. Arthritis Rheum 39: 623–628Google Scholar
  10. Becker KJ, McCarron RM, Hallenbeck JM (1997) Oral tolerance to myelin basic protein decreases stroke size. Stroke 28: 246Google Scholar
  11. Bergerot I, Fioix C, Peterson J, Moulin V, Bask C, Fabien N, Lindblad M, Mayer A, Czerkinsky C, Holmgren J, Thivolet C (1997) A cholera toxoid-insulin conjugate as an oral vaccine against spontaneous autoimmune diabetes. Proc Natl Acad Sci USA 94: 4610–4614PubMedGoogle Scholar
  12. Bieganowska KD, Ausubel LJ, Modabber Y, Slovik E, Messersmith W, Haller DA (1997) Direct ex vico analysis of activated Fas-sensitive autoreactive T cells in human autoimmune disease. J Exp Med 185: 1581 1594Google Scholar
  13. Bitar D, Whitacre CC (1988) Suppression of experimental autoimmune encephalomyelitis by the oral administration of myelin basic protein. Cell Immunol I I2: 364–370Google Scholar
  14. Blanas E, Carbone FR, Allison J, Miller JFAP, Heath WR (1996) Induction of autoimmune diabetes by oral administration of autoantigen. Science 274: 1707–1709PubMedGoogle Scholar
  15. Bridoux F, Badou A, Saoudi A, Bernard I, Druet E, Pasquier R, Druet P, Pelletier L (1997) Transforming growth factor b (TGF-b)-dependent inhibition of T helper cell 2 (Th2)-induced autoimmunity by self-major histocompatibility complex (MHC) class II-specific regulatory CD4+ T cell line. J Exp Med 185: 1769 1775Google Scholar
  16. Bruce MG, Ferguson A (1986a) The influence of intestinal processing on the immunogenicity and molecular size of absorbed circulating ovalbumin in mice. Immunology 59: 295 300Google Scholar
  17. Bruce MG, Ferguson A (19866) Oral tolerance to ovalbumin in mice: studies of chemically modified and of “biologically filtered” antigen. Immunology 57: 627–30Google Scholar
  18. C’ebra JJ, George A, Schrader CE (1991) A microculture containing TI-12 and dendritic cells supports the production of IgA by clones from both primary and IgA memory B cells and by single germinal center B cells from Peyer’s patches. Immunol Res 10: 389–392Google Scholar
  19. Challacombe SJ, Tomasi TB (1980) Systemic tolerance and secretory immunity after oral immunization. J Exp Med 152: 1459 1472Google Scholar
  20. Chase M (1946) Inhibition of experimental drug allergy by prior feeding of the sensitizing agent. Proc Soc Exp Biol Med 61: 257–259PubMedGoogle Scholar
  21. Chen Y, Hancock W, Marks R, Gonnella PA, Weiner HL (1997) Mechanisms of recovery from cell-mediated autoimmune disease: T cell deletion and immune deviation following encephalomyelitis in myelin basic protein T cell receptor transgenic mice. Cell Immunol (in press)Google Scholar
  22. Chen Y, Inobe J-I, Kuchroo VK, Baron JL, Janeway CA, Weiner HL (1996) Oral tolerance in myelin basic protein T-cell receptor transgenic mice: suppression of autoimmune encephalomyelitis and dose-dependent induction of regulatory cells. Proc Natl Acad Sci USA 93: 388 391Google Scholar
  23. Chen Y, Inobe J-I, Marks R, Gonnella P, Kuchroo VK, Weiner HL (1995a) Peripheral deletion of antigen-reactive T cells in oral tolerance. Nature 376: 177–180PubMedGoogle Scholar
  24. Chen Y, Inobe.I-I, Weiner HL (1995b) Induction of oral tolerance to myelin basic protein in CD-8 depleted mice: both CD4+ and CD8 + T cells mediate active suppression. J Immunol 156: 910 916Google Scholar
  25. Chen Y, Kuchroo VK, Inobe J-I, Haller DA, Weiner H L (1994) Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science 265: 1237 1240Google Scholar
  26. Chomarat P, Vannier E, Dechanet J, Dinnarelo CA, Miossec P (1995) Balance of Ill receptor antagonism/III beta in rheumatoid synovium and its regulation by IL-4 and IL-I0. J Immunol 154: 1432–39PubMedGoogle Scholar
  27. Coffman R, Lehman D, Shrader B (1989) Transforming growth factor beta (TGFb) specifically enhances IgA production by lipopolysaccharide-stimulated marine B lymphocytes. J Exp Med 144: 3411 16Google Scholar
  28. Coutant R, Zeidler A, Rappaport R, Schatz D, Schwartz S, Raskin P, Rogers D, Bode B, Crockett S, Marks J, Deeb L, Chalew S, MacLauren N (1998) Oral insulin therapy in newly diagnosed immune mediated (type I) diabetes. Preliminary analysis of a randomized, double-blind, placebo controlled study. Diabetes 47: A97Google Scholar
  29. Cross AH, Tuohy VK, Raine CS (1993) Development of reactivity to new myelin antigens during chronic relapsing autoimmune demyelination. Cell Immunol 146: 261 270Google Scholar
  30. Daynes R, Araneo B, Dowell T, Huang K, Dudley D (1990) Regulation of murine lymphokine production in vivo Ill The lymphoid tissue microenvironment exerts regulatory influences over T helper cell function. J Exp Med 171: 979–996PubMedGoogle Scholar
  31. Deeni RL, Targan SR (1995) The role of TOEh in molding the activation state of lamina propria T cells. Gastroenterology 108 (abstract)Google Scholar
  32. Desvinges C, Bour H, Nicolas JF, Kaiserlian D (1996) Lack of oral tolerance but oral priming for contact sensitivity to dinitrolluorobenzene in major histocompatihility complex class II-deficient mice and in CD4+ T cell-depleted mice. Eur J Immunol 26: 1756–1761Google Scholar
  33. Elson CO, Ealding W (1984) Cholera toxin feeding did not induce oral tolerance in mice and abrogated oral tolerance to an unrelated protein antigen..I Immunol 133: 2892 2897Google Scholar
  34. Elson CO, Tomasi M, Dertzbaugh MT, Thaggard G, Hunter R, Weaver C (1996) Oral antigen delivery by way of a multiple emulsion system enhances oral tolerance. In: Weiner HL, Mayer LF (eds) Oral tolerance: mechanisms and applications. Ann New York Acad Sci, New York, pp I56–162Google Scholar
  35. Fava RA, Olsen NJ, Postlethwaite AE, Broadley KN, Davidson JM, Nancy LB, Lucas C, Townes AS (1991) TGFb induced neutrophil recruitment to synovial tissues. J Exp Med 173: 1121–32PubMedGoogle Scholar
  36. Feldman M, Brennan FM, Maini RN (1996) Role of cytokines in rheumatoid arthritis. Ann Rev Immunol 14: 397–440Google Scholar
  37. Ferber IA, Brocke S, Taylor-Edwards C, Ridgway W, Dinisco C’, Steinman L, Dalton D, Fathman CG (1996) Mice with disrupted IFN-g gene are susceptible to the induction of experimental autoimmune encephalomyelitis ( EAE ). J Immunol I56: 5–7Google Scholar
  38. Frei K, Engster FI-P, Bopst M, Constantinescu CS, Lavi E, Fontana A (1997) Tumour necrosis factor a and lymphotoxin a are not required for induction of acute experimental autoimmune encephalomyelitis. J Exp Med 1852177–2182Google Scholar
  39. Friedman A, Weiner HL (1994) Induction of eanergy or active suppression following oral tolerance is determined by antigen dosage. Proc Natl Acad Sci USA 91: 6688–6692PubMedGoogle Scholar
  40. Fujihashi K, McGhee JR, Kweon MN, Cooper MD, Tonegawa S, Takahashi I, Hiroi T, Mestecky I, Kiyono H (1996) gad T Cell-deficient mice have impaired mucosal immunoglobulin A responses. J Exp Med 183: 1929–1935Google Scholar
  41. Fukaura H, Kent SC, Pietrusewicz MJ, Khoury SJ, Weiner HL, Haller DA (1996) Induction of circulating myelin basic protein and proteolipid protein specific TGE-b1 secreting Th3 T cells by oral administration of myelin in multiple sclerosis patients. J Clin Invest 98: 70 77Google Scholar
  42. Garside P, Steel M, Liew FY, Mowat AM (1995a) CD4+ but not CD8+ T cells are required for the induction of oral tolerance. Int Immunol 7: 501 504Google Scholar
  43. Garside P, Steel M, Worthey EA, Satoskar A, Alexander J, Bluethmann H, Liew FY, Mowat M (1995h) T helper 2 cells are subject to high dose oral tolerance and are not essential for its induction. J Immunol 154: 5649–5655PubMedGoogle Scholar
  44. Gonnella PA, Chen Y, Inobe i-I, Quartulli M, Weiner HL (1998) In situ immune response in gut associated lymphoid tissue (GA LT) following oral antigen in TeR transgenic mice. J Immunol 160: 4708 4718Google Scholar
  45. Groux H, O’Garra A, Bigler M, Rouleau M, Antonenko S, de Vries.1E, Roncarolo MG (1997) A CD4+ T cell subset inhibits antigen-specific T cell responses and prevents colitis. Nature 389: 737 742Google Scholar
  46. Haller DA, Duby AD, Lee SJ, Benjamin D, Seidman JG, Weiner HL (1988) Oligoclonal T-lymphocyte in the cerebrospinal fluid of patients with inflammatory central nervous system diseases..) Exp Med 167: 1313Google Scholar
  47. Haller DA, Weiner HL (1995) Immunologic mechanisms and therapy in multiple sclerosis. Immunol Rev 144: 75–107Google Scholar
  48. Hancock WW, Polanski M, Zhang ZJ, Blogg N, Weiner HL (1995) Suppression of insulitis in NOD mice by oral insulin administration is associated with selective expression of IL-4 IL-10 TGF-h and prostaglandin-E. Amer J Pathol 147: 1193–1199Google Scholar
  49. Harrison LC (1992) Islet cell antigens in insulin-dependent diabetes: Pandora’s box revisited. Immunol Today 13: 348–352PubMedGoogle Scholar
  50. Higgins P, Weiner HL (1988) Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein and its fragments. J Immunol 140: 440–445PubMedGoogle Scholar
  51. Hines KL, Christ M, Wahl M (1993) Cytokine regulation of the immune response: an in vivo model. Immunomethods 3: 13 22Google Scholar
  52. Hörnquist E, Lycke N (1993) Cholera toxin adjuvant greatly promotes antigen priming of T cells. Eur J Immunol 23: 2136–2143PubMedGoogle Scholar
  53. Husky S, Jensenius.IC, Svehag S-E (1986) Passage of undegraded dietary antigen into the blood of healthy adults. Further characterization of the kinetics of uptake and the size distribution of the antigen. Scand J Immunol 24: 447 452Google Scholar
  54. Husby S, Mestecky J, Moldoveanu Z, Holland S, Elson CO (1994) Oral tolerance in humans: T cell but not B cell tolerance after antigen feeding. J Immunol 152: 4663 4670Google Scholar
  55. Inobe J-I, Stavin AJ, Komagata Y, Chen Y, Liu L, Weiner HL (1998) II-4 is a differentiation factor for TGF-(3 secreting Th3 cells and oral administration of II-4 enhances oral tolerance in experimental allergic encephalomyelitis. Eur J Immunol 28: 2780 2790Google Scholar
  56. Janes SP, Kwan WC, Sneller MC ’ (1990) T cells in inductive and ellector compartments of intestinal mucosal immune system of non-human primates differ in lymphokine mRNA expression lymphokine utilization and regulatory function. Immunol 144: 1251 1256Google Scholar
  57. Kagnofl MF (1996) Essential of mucosal immunology. Kagnoll MF, Kagnofl KH (eds) Academic, San DiegoGoogle Scholar
  58. Karpus WJ, Lukacs NW (1996) The role of chemokines in oral tolerance: abrogation of nonresponsiveness by treatment with antimonocyte chemolactic protein-I. In: Weiner HL, Mayer LF (eds) Oral tolerance: mechanisms and applications. Ann New York Acad Sci, New York, pp 133–144Google Scholar
  59. Kasama T, Stricter RM, Lukacs NW, Lincoln PM, Burdick MD, Kunkel SL (1995) 0–10 expression and chemokine regulation during the evolution of murine type II CIA. Clin Invest 95: 2868 2876Google Scholar
  60. Ke Y, Kapp JA (1996) Oral antigen inhibits priming of CD8+ CTL CD4+ T cells and antibody responses while activating CD8+ suppressor. T cells.I Immunol 156: 916 921Google Scholar
  61. Ke Y, Pearce K, Lake JP, Ziegler HK, Kapp JA (1997) gd T lymphocytes regulate the induction and maintenance of oral tolerance. Immunol I58:36I0–3618Google Scholar
  62. Khalil N, Bereznay O, Sporn M, Greenberg AH (1989) Macrophage production of TGFb and fibroblast collagen synthesis in the chronic pulmonary inflammation. J Exp Med 170: 727 37Google Scholar
  63. Khoury SJ, Hancock WW, Weiner HL (1992) Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis as associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor b interleukin 4 and prostaglandin E expression in the brain. J Exp Med 176: 1355 1364Google Scholar
  64. Khoury SJ, Lider O, Al-Sabbagh A, Weiner HL (1990) Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein Ill. Synergistic effect of lipopolysaccharide. Cell Immunol 131: 302–310Google Scholar
  65. Kjerrulf M, Grdic D, Lycke N (1996) Impaired mucosal IgA responses but intact oral tolerance in IFN-g receptor deficient mice. FASEB J 10: A1418Google Scholar
  66. Kweon M, Fujihashi K, Yamamoto M, Van Colt JL, McGhee JR, Kiyono H (1996) Mucosally induced tolerance in IL-4-/-hut not IEN-g -/-mice. FASEB J 10: A1028Google Scholar
  67. Lehmann P, Forsthuber T, Miller A, Sercarz E (1992) Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen. Nature 358: 155 157Google Scholar
  68. Liblau RS, Singer SM, McDevitt HO (1995) Thl and Th2 CD4 T cells in the pathogenesis of organ-specific autoimmune diseases. Immunol Today 16: 34 38Google Scholar
  69. Lider O, Santos LMB, Lee CSY, Higgins PJ, Weiner HL (1989) Suppression of experimental allergic encephalomyelitis by oral administration of myelin basic protein II. Suppression of disease and in vitro immune responses is mediated by antigen-specific CD8+T lymphocytes. J Immunol 142: 748–752PubMedGoogle Scholar
  70. Lowney ED (1968) Immunologic unresponsiveness to a contact sensitizer in man.J Invest Dermatol 51: 411 417Google Scholar
  71. MacDonald TT (1983) lmmunosuppression caused by antigen feeding II Suppressor T cells mask Peyer’s patches B cell priming to orally administered antigen. Eur J Immunol 13:138 142Google Scholar
  72. Marinaro M, Boyaka PN, Finkelman ED, Kiyono H, Jackson R.I, Jirillo E, McGhee JR (1997) Oral but not parental interleukin (IL)-12 redirects T helper 2 (Th2)-type responses to an oral vaccine without altering mucosal IgA responses. J Exp Med 185: 415 427Google Scholar
  73. Maron R, Blogg NS, Polanski M, Hancock W, Weiner HL (1996) Oral tolerance to insulin and the insulin B-chain. Ann N Y Acad Sci 778: 346 357Google Scholar
  74. Marth T, Strober W, Kelsall BL (1996) High close oral tolerance in ovalbumin TCR-transgenic mice: systemic neutralization of IL-12 augments TGF-beta secretion and T cell apoptosis..I Immunol 157: 2348–2357Google Scholar
  75. Mattingly JA, Waksman BF! (1978) Immunologic suppression after oral administration of antigen I. Specific suppressor cells formed in rat Peyer’s patches after oral administration of sheep erythrocytes and their systemic migration.J Immunol 121: 1878 1882Google Scholar
  76. Meyer AL, Benson JM, Gienapp IE, Cox KL, Whitacre CC (1996) Suppression of murine chronic relapsing experimental autoimmune encephalomyelitis by the oral administration of myelin basic protein. J Immunol 157: 4230 4238Google Scholar
  77. Miller A, Al-Sabbagh A, Santos L, Das MP, Weiner HL (1993) Epitopes of myelin basic protein that trigger TGF-h release following oral tolerization are distinct from encephalitogenic epitopes and mediate epitope driven bystander suppression. J Immunol 151: 7307 7315Google Scholar
  78. Miller A, Lider O, Abramsky O, Weiner ElL (1994) Orally administered myelin basic protein in neonates princes for immune responses and enhances experimental autoimmune encephalomyelitis in adult animals. Eur J Immunol 24: 1026–1032PubMedGoogle Scholar
  79. Miller A, Lider O, Al-Sabbagh A, Weiner H (1992a) Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein V. Hierarchy of suppression by myelin basic protein from different species. J Neuroimmunol 39: 243 250Google Scholar
  80. Miller A, Lider O, Roberts AB, Sporn MB, Weiner HL (1992b) Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of TGFb following antigen specific triggering. Proc Natl Acad Sci USA 89: 421 425Google Scholar
  81. Miller A, Lider O, Weiner H L (1991) Antigen-driven bystander suppression following oral administration of antigens. J Exp Med 174: 791 798Google Scholar
  82. Miller S, Hanson D (1979) Inhibition of specific immune responses by feeding protein antigens IV. Evidence for tolerance and specific active suppression of cell-mediated immune responses to ovalbumin. J Immunol 123: 2344Google Scholar
  83. Miossee P, Briolay J, Dechanet.I, Wijdenes J, Martinez- Valdez H, Banchereau.I (1992) Inhibition of the production of proinllammatory cytokines and Ig by IL-4 in an ex vivo model of rheumatoid synovitis. Arthritis Rheum 35: 874–883Google Scholar
  84. Moore KW, O’Garra A, de Waal Malefyt R, Vies P, Mosman TR (1993) Interleukin 10. Ann Rev Immunol 11: 165 190Google Scholar
  85. Mosmann TR, Sad S (1996) The expanding universe of T-cell subsets: Tht Th2 and more. Immunol Today 17: 138 146Google Scholar
  86. Mowat AM (1987) The regulation of immune responses to dietary protein antigens. Immunol Today 8: 93 98Google Scholar
  87. Nagler-Anderson C’, Bober LA, Robinson ME, Siskind OW, Thorbeke FJ (1986) Suppression of type II collagen-induced arthritis by intragastric administration of soluble type II collagen. Proc Natl Acad Sci USA 83: 7443 7446Google Scholar
  88. Nelson PA, Akselhand Y, Dearborn S, Al-Sabbagh A, Tian Z.1, Gonnella P, Zamvil S, Chen Y, Weiner H L (1996) Effect of oral beta interferon on subsequent immune responsiveness. In: Weiner HL, Mayer LE (eds) Oral tolerance: mechanisms and applications. New York Acad Sci, New York, pp 145 155Google Scholar
  89. Neutra RM, Kraehenbuhl i-P (1996) M cells as a pathway for antigen uptake and processing. In: Kagnolf MF, Kiyono H teds) Essentials of mucosal immunology Academic, San Diego, pp 29–33Google Scholar
  90. Newby TJ (1984) Protective immune responses in the intestinal tract In: Newby TJ, Stokes CR (eds) Local immune responses of the gut. CRC, Boca Raton, Florida, pp 143–198Google Scholar
  91. Ngan J, Kind LS (1978) Suppressor T cells for IgE and 1gG in Peyer’s patches of mice made tolerant by the oral administration of ovalbumin..l Immunol 120: 861 865Google Scholar
  92. Nussenblatt RB, fiery I, Weiner HL, Ferris F, Shiloach J, Ramaley N, Perry C, Caspi R, Haller DA, Foster S, Whitcup SM (1997) Treatment of uveitis by oral administration of retinal antigens: Results of a Phase I/II randomized masked trial. Am J Opthalmol 123: 583–592Google Scholar
  93. Peng Hi, Turner MW, Strobel S (1990) The generation of a “tolerogen” after the ingestion of ovalbumin is time-dependent and unrelated to serum levels of immunoreactive antigen. Clin Exp Immunol 81: 510–515Google Scholar
  94. Powrie F, Carlino J, Leach MW, Mauze S, Coffman RL (1996) A critical role for transforming growth factor-beta but not interleukin 4 in the suppression of T helper type I-mediated colitis by CD45RB (low) CD4 + T cells. J Exp Med 183: 2669–2674PubMedGoogle Scholar
  95. Richman LK, Chiller JM, Brown WR, Hanson DO, Vaz NM (1978) Enterically induced immunological tolerance I Induction of suppressor T lymphocytes by intragastric administration of soluble proteins. J Immunol 121: 2429 2433Google Scholar
  96. Rizzo LV, Miller-Rivero NE, Chan C-C’, Wiggert B, Nussenblatt RB, Caspi RR (1994) Interleukin-2 treatment potentiates induction of oral tolerance in a marine model of autoimmunity. Clin Invest 94: 1668 1672Google Scholar
  97. Rollwagon FM and Baqar S (1996) Oral cytokine administration. Immunol Today 17: 548 550Google Scholar
  98. Santos LMB, Al-Sabbagh A, Londono A, Weiner HL (1994) Oral tolerance to myelin basic protein induces regulatory TGF-(3-secreting T cells in Peyer’s patches of SJL mice. Cell Immunol 157: 439 447Google Scholar
  99. Seder RA, Marth T, Sieve MC, Strober W, Letterio II, Roberts AB, Kelsall B (1998) Factors involved in the differentiation of TGF-15 producing cells from naive CD4+ T cells: IL-4 and IFN-y have opposing effects, while TGF-(3 positively regulates its own production.. Immunol 160: 5719 5728Google Scholar
  100. Sieper J, Kary S, Sörensen H, Alten R, Eggens U, Huge W, Hiepe F, Kühne A, Listing J, Ulbrich N, Braun J, Zink A, Mitchison NA (1996) Oral type II collagen treatment in early rheumatoid arthritis. Arthritis Rheum 39: 41–51PubMedGoogle Scholar
  101. Strobel S (1990) Mechanisms of gastrointestinal immunoregulation and food induced injury to the gut. Eur.1 Clin Nutr 45: 1–9Google Scholar
  102. Sun J-B, Holmgren C, Czerkinsky C (1994) Cholera toxin B subunit: an efficient transmucosal carrier-delivery system for induction of peripheral immunological tolerance. Proc Nall Acad Sci USA 91: 10795–10799Google Scholar
  103. Sun.IB, Rask C, Olsson T, Holmgren J, Czerkinsky C (1996) Treatment of experimental autoimmune encephalomyelitis by feeding myelin basic protein conjugated to cholera toxin B subunit. Proc Natl Acad Sci USA 93: 7196 7201Google Scholar
  104. Tada Y, Ho A, Koh DR, Mak TW (1996) Collagen-induced arthritis in CD4- or CD8- deficient mice. J Immunol I56: 4520 4526Google Scholar
  105. Terato K, Xiu JY, Miyahara H, Cremer MA, Griffiths MM (1996) Induction of chronic autoimmune arthritis in DBA/I mice by oral administration of type II collagen and Escherichia coli lipopolysacclaride. Brit J Rheumatol 35: 1 11Google Scholar
  106. Thompson HS, Staines NA (1986) Suppression of collagen-induced arthritis with pregastrically or intravenously administered type II collagen. Agents Actions I9: 318–319Google Scholar
  107. Thorbecke GJ, Shah R, Leu CH, Kuruvilla AP, Hardison AM, Palladino MA (1992) Involvement of endogenous TNFa and TGFb during induction of collagen type 11 arthritis in nice. Proc Natl Acad Sci USA 89: 7375–7379PubMedGoogle Scholar
  108. Trentham DE, Dynesius-Trentham RA, Gray EJ, Combitchi D, Lorenzo C, Sewell KL, Haller DA, Weiner HL (1993) Effects of oral administration of type 11 collagen on rheumatoid arthritis. Science 261: 1727–1730PubMedGoogle Scholar
  109. Vajdy M, Kosco-Vilbois MH, Kopf M, Köhler G, Lycke N (1995) Impaired mucosal immune responses in interleukin 4-targeted mice. J Exp Med 181: 41–53PubMedGoogle Scholar
  110. Vaz NM, Maia LCS, Hanson DG, Lynch JM (1977) Inhibition of homocytotropic antibody responses in adult inbred mice by previous feeding of the specific antigen. J Allergy Clin Immunol 60: 110 115Google Scholar
  111. von Herrath MG, Dyrberg T, Oldstone MBA (1996) Oral insulin treatment suppresses virus-induced antigen-specific destruction of beta cells and prevents autoimmune diabetes in transgenic mice. J Clin Invest 98: 1324 1331Google Scholar
  112. Wahl S (1992) Transforming growth factor beta (TGFb) in inflammation: a cause and a cure Clin Immunol 12: 61 74Google Scholar
  113. Wahl SM (1994) TGFb: the good the had and the ugly. J Exp Med 180: 1587 90Google Scholar
  114. Wahl SM, Allen JB, Costa GL, Wong HL, Dasch JR (1993) Reversal of acute and chronic synovial inflammation by anti-TGFb. J Exp Med 177: 225 230Google Scholar
  115. Waldo FB, Van Den Wall Bake AWL, Mestecky J, Husby S (1994) Suppression of the immune response by nasal immunization. Clin Immunol Immunopathol 72: 30 34Google Scholar
  116. Weiner H L (1997) Oral tolerance: immune mechanisms and treatment of autoimmune diseases. Immunol Today 18: 335 343Google Scholar
  117. Weiner HL, Friedman A, Miller A, Khoury Si, Al-Sabbagh A, Santos LMB, Sayegh M, Nussenblatt RB, Trentham DE, Haller DA (1994) Oral tolerance: Immunologic mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens. Ann Rev Immunol 12: 809–837Google Scholar
  118. Weiner HL, Inobe.I-I, Kuchroo V, Chen Y (1996) Induction and Characterization of TGF-beta secreting Th3 cells. FASEB J 10: A1444Google Scholar
  119. Weiner HL, Mayer LF (1996) Oral tolerance: mechanisms and applications. Ann N Y Acad Sci, New York, pp 1 453Google Scholar
  120. Wilson AD, Bailey M, Williams NA, Stokes CR (1991) The in vitro production of cytokines by mucosal lymphocytes immunized by oral administration of keyhole limpet hemocyanin using cholera toxin as an adjuvant. Eur J Immunol 21: 2333 2339Google Scholar
  121. Wright JK, Cawston TE, Hazelman BL (1991) TGFb stimulates the production of tissue inhibitor of metalloproteinases (TIM P) by human synovial and skin fibroblasts. Biochem Biophys Acta 1094: 207 210Google Scholar
  122. Xu-Amano J, Kiyono H, Jackson RI, Staats HF, Fujihashi K, Burrows PD, Elson CO, Pillai S, McGhee JR (1990) Helper T cell subsets for immunoglobulin A responses: oral immunization with tetanus toxoid and cholera toxin as adjuvant selectively induces Th2 cells in mucosa associated tissues. J Exp Med 178: 1309–1320Google Scholar
  123. Yoshino S, Quattrocchi E, Weiner HL (1995) Oral administration of type II collagen suppresses antigen-induced arthritis in Lewis rats. Arthritis Rheum 38: 1092 1096Google Scholar
  124. Zhang J, Markovic S, Raus J, Lacet B, Weiner HL, Haller DA (1993) Increased frequency of IL-2 responsive T cells specific for myelin basic protein and proteolipid protein in peripheral blood and cerebrospinal fluid of patients with multiple sclerosis. J Exp Med 179: 973–984Google Scholar
  125. Zhang JZ, Lee CSY, Lider O. Weiner HL (1990) Suppression of adjuvant arthritis in Lewis rats by oral administration of type I1 collagen. J Immunol 145: 2489–2493Google Scholar
  126. Zhang Z, Michael J (1990) Orally inducible immune unresponsiveness is abrogated by IFN-g treatment. J Immunol 144: 4163–4165PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1999

Authors and Affiliations

  • G. Garcia
    • 1
  • H. L. Weiner
    • 1
  1. 1.Center for Neurologic Diseases, Brigham and Women’s HospitalHarvard Medical SchoolBostonUSA

Personalised recommendations